Novel pathogenic genomic variants leading to autosomal dominant and recessive Robinow syndrome
Robinow syndrome (RS) is a genetically heterogeneous disorder characterized by skeletal dysplasia and a distinctive facial appearance. Previous studies have revealed locus heterogeneity with rare variants in DVL1, DVL3, FZD2, NXN, ROR2, and WNT5A underlying the etiology of RS. The aforementioned “Ro...
Saved in:
Published in | American journal of medical genetics. Part A Vol. 185; no. 12; pp. 3593 - 3600 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.12.2021
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Robinow syndrome (RS) is a genetically heterogeneous disorder characterized by skeletal dysplasia and a distinctive facial appearance. Previous studies have revealed locus heterogeneity with rare variants in DVL1, DVL3, FZD2, NXN, ROR2, and WNT5A underlying the etiology of RS. The aforementioned “Robinow‐associated genes” and their gene products all play a role in the WNT/planar cell polarity signaling pathway. We performed gene‐targeted Sanger sequencing, exome sequencing, genome sequencing, and array comparative genomic hybridization on four subjects with a clinical diagnosis of RS who had not had prior DNA testing. Individuals in our cohort were found to carry pathogenic or likely pathogenic variants in three RS related genes: DVL1, ROR2, and NXN. One subject was found to have a nonsense variant (c.817C > T [p.Gln273*]) in NXN in trans with an ~1 Mb telomeric deletion on chromosome 17p containing NXN, which supports our contention that biallelic NXN variant alleles are responsible for a novel autosomal recessive RS locus. These findings provide increased understanding of the role of WNT signaling in skeletal development and maintenance. These data further support the hypothesis that dysregulation of the noncanonical WNT pathway in humans gives rise to RS. |
---|---|
Bibliography: | Funding information Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant/Award Number: R03HD092569; National Human Genome Research Institute, Grant/Award Number: UM1HG006542; National Institute of Neurological Disorders and Stroke, Grant/Award Number: R35 NS105078; Swedish Research Council, Grant/Award Number: 2017‐02936 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Author Contributions C.Z., J.R.L. and C.M.B.C.: designed the study and take responsibility for the integrity of the data and accuracy of the data analysis. C.Z., J.F.M., C.M.G., J.W., V.R.S. and C.M.B.C.: collected the data. J.E. and A.L.: performed genome sequencing and structural variant analysis. Z.C.A., S.N.J., D.M.M., and R.A.G.: performed exome sequencing and variant annotation. C.Z.: analyzed data and wrote the initial manuscript draft. J.R.L., V.R.S. and C.M.B.C.: provided critical input into the writing of the manuscript. All the authors: were involved in reviewing and revising the final submitted manuscript. |
ISSN: | 1552-4825 1552-4833 1552-4833 |
DOI: | 10.1002/ajmg.a.61908 |